Sydney Oesch 10/21/25 Sydney Oesch 10/21/25

Survivorship

This is the last episode of our core curriculum series. In this episode we discuss cancer survivorship as it relates to gynecologic oncology. Additionally we provide a framework for surveillance visits as well the general timing based on primary malignancy. We also give a brief overview of hormone replacement therapy versus hormone therapy in the survivor.

Sydney Oesch 9/23/25 Sydney Oesch 9/23/25

Surgical Management of Placenta Accreta

In this episode, we discuss placenta accreta spectrum, including diagnosis, preoperative and intraoperative optimization and management, as well as alternative approaches to management of PAS.

Sydney Oesch 6/25/24 Sydney Oesch 6/25/24

Ovary Part 2

This is the second of seven episodes covering ovarian cancer. In this episode, we discuss the management of advanced stage epithelial ovarian cancer. Join us to learn about the importance of optimal debulking, options for up-front treatment, the utility of bevacizumab, and the use of PARP inhibitors.

Sydney Oesch 5/28/24 Sydney Oesch 5/28/24

Uterine Cytotoxic Therapies

In our second chemotherapy episode, we will explore some commonly used cytotoxic therapies in gynecologic oncology. Specifically, we will discuss in detail mechanisms of action, side effects, and other considerations of individual cytotoxic agents used in the treatment of uterine cancers.

Sydney Oesch 5/14/24 Sydney Oesch 5/14/24

Chemotherapy principles

In our first chemotherapy episode, we will explore the fundamental principles of tumor growth and chemotherapy. We will discuss tumor growth kinetics, theory behind combination chemotherapy and dosing cycles, pharmacokinetics, how to calculate doses for certain agents, and how to determine whether a therapy regimen is effective for a patient.